Therapeutic Apheresis

Published by: Global Industry Analysts

Published: Aug. 1, 2006 - 140 Pages

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definitions and Scope of Study

A Peek into the above-mentioned procedures

Plasmapheresis

Immunoadsorption

Erythrocytapheresis

Plateletpheresis

Leukapheresis

Photopheresis

Lipidpheresis

II. A US MARKET REPORT

1. Market Analysis

A Current & Future Analysis

A Promising Outlook

2. Market Trends

Apheresis Process Leads to Rise in Platelet Donors

Therapeutic Apheresis Devices - A Perplexing Market

Plateletpheresis: The Treatment of Choice for Patients

Photopheresis Market Growing at a High Rate

Vendors’ Attitude Hampers Growth Prospects of Therapeutic Apheresis

Developing New Applications for Therapeutic Apheresis is the Need of the Hour

CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease

3. Competitive Scenario

Overview

Technology: The Only Key for Success

Gambro BCT: The World Leader

Market Share Trends

By Procedures (Revenues)

Table 1: US Market for Therapeutic Apheresis (2002 & 2005): Percentage Breakdown of Revenues by Company for Gambro BCT, Therakos, Fresenius Hemocare, Kaneka Pharma America Corporation, Baxter Transfusion Therapies , and Others (includes corresponding Graph/Chart)

By Procedures (Number of Procedures)

Table 2: US Market for Therapeutic Apheresis (2002 & 2005): Percentage Breakdown of Number of Procedures by Company for Gambro BCT, Therakos, Fresenius HemoCare, Haemonetics, Baxter Transfusion Therapies, and Others (includes corresponding Graph/Chart)

By Neurology Disorders (Revenues)

Table 3: US Market for Therapeutic Apheresis in Neurological Disorders (2002 & 2005): Percentage Breakdown of Revenues by Company for Gambro BCT, Fresenius HemoCare, Haemonetics, and Others (includes corresponding Graph/Chart)

By Neurology Disorders (Number of Procedures)

Table 4: US Market for Therapeutic Apheresis in Neurological Disorders (2002 & 2005): Percentage Breakdown of Number of Procedures by Company for Gambro BCT, Fresenius HemoCare, Haemonetics , and Others (includes corresponding Graph/ Chart)

By Hematology and Oncology Disorders (Revenues)

Table 5: US Market for Therapeutic Apheresis in Hematology and Oncology Disorders (2002 & 2005): Percentage Breakdown of Revenues by Company for Gambro BCT, Therakos, Fresenius HemoCare, Baxter Transfusion Therapies, , and Others (includes corresponding Graph/Chart)

By Hematology and Oncology (Number of Procedures)

Table 6: US Market for Therapeutic Apheresis in Hematology and Oncology Disorders in (2002 & 2005): Percentage Breakdown of Number of Procedures by Company for Gambro BCT, Fresenius HemoCare, Baxter Transfusion Therapies, Therakos, , and Others (includes corresponding Graph/Chart)

4. Market Overview & Outlook

Market Drivers

New Reimbursement Policies Create Growth Opportunities for Therapeutic Apheresis

Increased Industry Consolidation Drives Research

Development of New Technology

Research Unveils Novel Applications

Market Restraints

Lack of Awareness Restrains Growth

Therapeutic Apheresis Costs Still a Concern

Market Challenges

Development of Inexpensive Apheresis Therapy

Scarcity of Qualified Donors

Pediatry: An Untapped Opportunity

5. Regulatory Environment

6. Product Overview

Therapeutic Apheresis: An Introduction

Overview of Therapeutic Apheresis

Blood Components

Apheresis and Therapeutic Apheresis: The Difference

Therapeutic Apheresis Process

Duration, Frequency, and Efficiency of Therapeutic Apheresis

Segregation of Blood Components

Centrifugation

Filtration

History

Kinds of Therapeutic Apheresis Procedures

Plasmapheresis

Erythrocytapheresis

Plateletpheresis

Leukapheresis

Stem Cell Apheresis

Photopheresis

Lipidpheresis

Cytapheresis

Immunoadsorption

Rheopheresis

Therapeutic Apheresis is Remedial for Various Diseases

7. Product Trends and Issues

Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement

Risks Associated with Therapeutic Apheresis

Categories of Indications for Therapeutic Apheresis

Plasma Exchange and Plasmapheresis: The Difference

Applications of Plasma Exchange

Chronic Diseases

Acute Self-Limited Disease

Emerging Applications

8. Technological Developments

HemoCleanse to Develop Novel Plasmapheresis Device

Aethlon Develops a New Device to Remove HIV

Therapeutic Plasmapheresis for Treatment of Autoimmune Diseases

Occulogix Offers Blood-Filtering Treatment for Macular Degeneration

9. Recent Industry Activity

Fresenius Medical Care Takes Over Renal Care

Haemonetics Signs Acquisition Agreement with Arryx

Renal Care Pockets Bay Area Mobile Apheresis Program..

Haemonetics Pacts with FMCEA

PhereSys and ACGT Ink Consulting Services Pact

CHF Forges a Service Provider Pact with FMCEA

Otsuka America Inks a Pact with HemaCare

Gambro Acquires Ivex

Alpha Therapeutic Sells Assets to Probitas Pharma and Baxter

Gambro Signs Agreement with The American Red Cross

Gambro Receives Contract from NBS

FMC-EA Inks with Allina Hospitals

Gambro Starts a New Company, Navigant Biotechnologies

Gambro’s Vista™ Receives Approval from FDA

Gambro’s New Anticoagulant Solution Receives FDA Approval

Gambro BCT Receives FDA Clearance for New Filter Tubing Sets Developed by Pall

Gambro Launches Trima Accel Automated Blood Collection System

Fresenius HemoCare Acquires PROSORBA® Column from Cypress Bioscience

Gambro Buys the Assets of Sanguistech

Haemonetics Inks Purchase Agreement with Alpha Therapeutic Corp

Gambro Joins Forces with the Walter Reed Army Institute of Research

Gambro Collaborates with Dendreon for Commercialization of Therapeutic Vaccines

Gambro AB Enters into a Partnership with Sangart

WakeMed Awards a Contract to HemaCare’s Subsidiary

HemaCare’s Subsidiary Coral in Agreement with CMH

BioTransplant Inks an Exclusive Distribution Agreement with Gambro BCT

Gambro BCT Receives US Patent for its Pathogen Inactivation Technology

Gambro’s Trima Receives Approval of The Japanese Red Cross Society

Gambro BCT Test Launches the Vista™ Information System

HemaCare Enters into a Partnership with LBMMC

10. Focus on Select Players

Baxter Healthcare Corporation

Baxter Transfusion Therapies

Fresenius Medical Care North America (FMCNA)

Fresenius HemoCare

Fresenius Medical Care Extracorporeal Alliance (FMCEA)

Gambro Blood Component Technologies (BCT)

Haemonetics Corporation

HemaCare Corporation

Therakos, Inc.

11. Market Perspective

Table 7: US Recent Past, Current & Future Market Analysis for Therapeutic Apheresis by Procedure - Plasmapheresis, Immunoadsorption, Erythrocytapheresis, Plateletpheresis, Leukapheresis, Photopheresis and Lipidpheresis Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2000 through 2010 (includes corresponding Graph/ Chart)

Table 8: US Recent Past, Current & Future Market Analysis for Therapeutic Apheresis by End Use - Neurology Disorders, Hematology and Oncology Disorders, Rheumatology Disorders and Other Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 9: US 10-Year Perspective for Therapeutic Apheresis by Procedure - Percentage Breakdown of Dollar Revenues for Plasmapheresis, Immunoadsorption, Erythrocytapheresis, Plateletpheresis, Leukapheresis, Photopheresis and Lipidpheresis Markets Independently Analyzed for 2000, 2005 & 2010 (includes corresponding Graph/Chart)

Table 10: US 10-Year Perspective for Therapeutic Apheresis by End Use - Percentage Breakdown of Dollar Revenues for Neurology Disorders, Hematology and Oncology Disorders, Rheumatology Disorders and Other Markets Independently Analyzed for 2000, 2005 & 2010 (includes corresponding Graph /Chart)

III. COMPETITION

1. Aethlon Medical, Inc. (USA)

2. American Red Cross (USA)

3. B Braun Medical, Inc. (USA)

4. Baxter International, Inc. (USA)

Table 11: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 12: Half Yearly Sales Analysis by Segment: 2005- 2006 (H1) (In US$ million)

Table 13: Quarterly Sales Analysis: 2004-2005 (In US$ million)

Table 14: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 15: Annual Sales Analysis by Geographical Region: 2004-2005 (In US$ million)

Table 16: Annual Sales Analysis: 2004 - 2005 (In US$ million)

Baxter Healthcare Corporation (USA)

Baxter Transfusion Therapies (USA)

5. BRT Laboratories, Inc. (USA)

6. CHF Solutions, Inc. (USA)

7. Cypress Bioscience, Inc. (USA)

8. Dyax Corporation (USA)

Table 17: First Quarter Sales Analysis: 2005-2006 (Q1) (In US$ million)

Table 18: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 19: Quarterly Sales Analysis: 2004-2005 (In US$ million)

9. Fresenius AG (Germany)

Table 20: Half Yearly Sales Analysis: 2005-2006 (H1) (In € million)

Table 21: Half Yearly Sales Analysis by Business Segment: 2005-2006 (H1) (In € million)

Table 22: Half Yearly Sales Analysis By Geographical Region: 2005-2006 (H1) (In € million)

Table 23: Annual Sales Analysis: 2004-2005 (In € million)

Table 24: Annual Sales Analysis by Business Segment: 2004-2005 (In € million)

Fresenius Medical Care AG & Co. KGAA (Germany)

Table 25: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 26: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 27: Annual Sales Analysis By Product Segment: 2004-2005 (In US$ million)

Table 28: Annual Sales Analysis By Geographic Region: 2004-2005 (In US$ million) (Germany))

Fresenius Hemocare (USA)

Fresenius Medical Care Extracorporeal Alliance (FMCEA) (USA)

Fresenius Medical Care North America (FMCNA) (USA)

10. Gambro AB (Sweden)

Table 29: Annual Sales Analysis: 2004-2005 (In MSEK million)

Table 30: Annual Sales Analysis by Segment: 2004-2005 (In SEK million)

Table 31: Annual Sales Analysis by Region: 2004-2005 (In SEK million)

Gambro BCT, Inc. (USA)

11. Haemonetics Corporation (USA)

Table 32: First Quarter Sales Analysis: 2006-2007 (Q1) (In US$ million)

Table 33: First Quarter Sales Analysis by Product: 2006-2007 (Q1) (In US$ million)

Table 34: First Quarter Sales Analysis by Geographic Region: 2006-2007 (Q1) (In US$ million)

Table 35: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 36: Quarterly Sales Analysis: 2005-2006 (In US$ million)

12. Hemacare Corporation (USA)

Table 37: First Quarter Sales Analysis by Segment: 2005-2006 (In US$ million)

Table 38: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ thousands)

Table 39: Quarterly Sales Analysis: 2004-2005 (In US$ thousands)

13. HemoCleanse, Inc. (USA)

14. Kaneka Pharma America Corporation (USA)

15. Miltenyi Biotec GmbH (Germany)

16. OccuLogix, Inc. (Canada)

Table 40: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$)

Table 41: Annual Sales Analysis: 2004-2005 (In US$)

Table 42: Annual Sales Analysis by Segment: 2004-2005 (In US$)

17. Pall Corporation (USA)

Table 43: Nine Months Sales Analysis: 2004-2005 (Nine Months Ended, April) (In US$ million)

Table 44: Nine Months Sales Analysis by Segment: 2004- 2005 (Nine Months Ended, April) (In US$ million)

Table 45: Nine Months Sales Analysis by Geographic Region: 2004-2005 (Nine Months Ended, April) (In US$ million)

Table 46: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 47: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 48: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

18. Pheresys Therapeutics Corporation (USA)

19. Rita Medical Systems, Inc. (USA)

Table 49: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 50: Half Yearly Sales Analysis by Product: 2005- 2006 (H1) (In US$ million)

Table 51: Annual Sales Analysis by Products: 2004-2005 (In US$ million)

Table 52: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

20. Teva Pharmaceutical Industries Ltd. (Israel)

Table 53: First Quarter Sales Analysis: 2005-2006 (In US$ million)

Table 54: Quarterly Sales Analysis: 2004-2005 (In US$ million)

21. Therakos, Inc. (USA)

22. Verax Biomedical, Inc. (USA)

Abstract

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location. Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your personal library immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.